November 2022 Journal Club

Association between alopecia areata andretinal diseases: A nationwide population-based cohort study

DWI_I_ IL-36 AND GENERALIZED PUSTULAR PSORIASIS_ L’CHAIM!

JAAD_ Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy

JAAD-SLN bx in patients with IIB_C melanoma

JAMA_ Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records

jamadermatology_chingroa_2022_oi_220046_1666117411.5783-3

jamadermatology_guitart_2022_oi_220044_1666117416.37488 (1)

JID Safety and Efficacy of Lenabasum

One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial

JID: Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

JAAD: One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial

November Journal Club_3 – Robert Duffy

Link to files on Google Drive >>